Inhibited, trapped or adducted: the optimal selective synthetic lethal mix for BRCAness
Ann Oncol
.
2018 Jan 1;29(1):18-21.
doi: 10.1093/annonc/mdx775.
Author
A Tutt
1
2
Affiliations
1
Breast Cancer Now Research Centre, Institute of Cancer Research, London, UK.
2
Research Oncology, Kings College London, London, UK.
PMID:
29300815
PMCID:
PMC5834033
DOI:
10.1093/annonc/mdx775
No abstract available
Publication types
Comment
MeSH terms
Benzimidazoles
Breast Neoplasms*
Carboplatin
Humans
Neoplasm Recurrence, Local
Paclitaxel
Temozolomide
Substances
Benzimidazoles
veliparib
Carboplatin
Paclitaxel
Temozolomide